744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

Clicks: 115
ID: 269473
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
hong2016european744 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors S.J. Kim,S. Hong,H.J. Kim,D. You,I.G. Jeong,C. Song,B.S. Hong,C.S. Kim,H. Ahn,J.H. Hong;S.J. Kim;S. Hong;H.J. Kim;D. You;I.G. Jeong;C. Song;B.S. Hong;C.S. Kim;H. Ahn;J.H. Hong;
Journal european urology supplements
Year 2016
DOI
10.1016/s1569-9056(16)60746-7
URL
https://sciprofiles.com/publication/view/b1131bc13c52fddf4176f878179cab24
Keywords
new classification indolent clinical pta bladder associated pta bladder tumour calmette gurine situ associated

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.